Skip to main content

What the FDA labels say about taking them together

Digoxin and vibegron

Vibegron's FDA label of April 1, 2025 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name vibegron. The vibegron label: “DRUG INTERACTIONS Concomitant use of GEMTESA increases digoxin maximal concentrations (C max ) and systemic exposure as assessed by area under the concentration-time curve (AUC).”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the vibegron FDA label on DailyMed (effective April 1, 2025, Sumitomo Pharma America, Inc.).

What does the digoxin label say about vibegron?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name vibegron in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the vibegron label say about digoxin?

Vibegron label, drug interactions

DRUG INTERACTIONS Concomitant use of GEMTESA increases digoxin maximal concentrations (C max ) and systemic exposure as assessed by area under the concentration-time curve (AUC) [see Clinical Pharmacology ( 12.3 )].

Source: FDA drug label (GEMTESA), Sumitomo Pharma America, Inc., effective April 1, 2025 (SPL set 25f21d25-14f8-4fda-91f6-7aa8b68aa1c8), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
0Vibegron generic labelers
DigoxinVibegron
Labeled forHeart failure, Atrial fibrillationOveractive bladder
Boxed warningNoNo
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tablet$16.46 per tablet 75 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?